These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 25388058)

  • 1. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
    Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
    Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
    Batawil N; Alkordy T
    Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.
    Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
    Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
    Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.
    Saiegh L; Shechner C; Dickstein G; Sheikh-Ahmad M; Reut M; Odeh M; Toubi A; Bejar J
    Minerva Endocrinol; 2014 Mar; 39(1):43-52. PubMed ID: 24513603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
    Sahin M; Gursoy A; Tutuncu NB; Guvener DN
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
    Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
    Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bethesda III thyroid nodules: the role of ultrasound in clinical decision making.
    Norlén O; Popadich A; Kruijff S; Gill AJ; Sarkis LM; Delbridge L; Sywak M; Sidhu S
    Ann Surg Oncol; 2014 Oct; 21(11):3528-33. PubMed ID: 24806117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration of the thyroid: correlating suspicious cytology results with histological outcomes.
    Baynes AL; Del Rio A; McLean C; Grodski S; Yeung MJ; Johnson WR; Serpell JW
    Ann Surg Oncol; 2014 May; 21(5):1653-8. PubMed ID: 24390657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid?
    Sippel RS; Elaraj DM; Khanafshar E; Kebebew E; Duh QY; Clark OH
    Surgery; 2007 Dec; 142(6):851-7; discussion 857.e1-2. PubMed ID: 18063067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
    Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
    Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
    Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
    Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid nodule size and prediction of cancer.
    Kamran SC; Marqusee E; Kim MI; Frates MC; Ritner J; Peters H; Benson CB; Doubilet PM; Cibas ES; Barletta J; Cho N; Gawande A; Ruan D; Moore FD; Pou K; Larsen PR; Alexander EK
    J Clin Endocrinol Metab; 2013 Feb; 98(2):564-70. PubMed ID: 23275525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
    Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
    Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience.
    Rossi ED; Straccia P; Martini M; Revelli L; Lombardi CP; Pontecorvi A; Fadda G
    Cancer Cytopathol; 2014 May; 122(5):359-67. PubMed ID: 24474727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland.
    Petric R; Besic H; Besic N
    World J Surg Oncol; 2014 Sep; 12():282. PubMed ID: 25213012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.